Latest / Pharmacy Podcast Network / ASX 25: Access to Pharmacy in Las Vegas | Part Two sponsored by Lumicera
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession.
- 0:10Speaker 2: Welcome to the Pharmacy Podcast Network.
- 0:28Speaker 3: Hello, and welcome back to part two of our Assembia
- 0:31Speaker 3: twenty twenty five recap series, where we're sharing conversations with
- 0:34Speaker 3: attendees and exhibitors from this year's Access to Pharmacy Conference
- 0:38Speaker 3: in Las Vegas. We've got more great insights lined up today,
- 0:42Speaker 3: from what's making waves and pharmacy access to the real
- 0:45Speaker 3: world conversations shaping the future of care. This episode is
- 0:48Speaker 3: brought to you by loumis Era.
- 0:50Speaker 4: Seventy eight percent of physicians reported in a national survey
- 0:53Speaker 4: that authorizations often led to patients not receiving their treatment.
- 0:58Speaker 4: Louis Sarrah's specialists in farm work and a coordinate effort
- 1:01Speaker 4: as part of the patient care team to reduce that
- 1:04Speaker 4: authorization burden and get patients on therapy quickly to obtain
- 1:08Speaker 4: those desired outcomes from their treatment.
- 1:11Speaker 5: Eric Hutkins is the vice president of Business Development of
- 1:14Speaker 5: Lumis Sarrah Health Services, sponsoring the Pharmacy Podcast Network at
- 1:19Speaker 5: Access to Pharmacy twenty twenty five. Here at Assembia, Eric,
- 1:30Speaker 5: Welcome back to the show. How are you doing well?
- 1:32Speaker 6: Doing well?
- 1:33Speaker 5: Thanks tod Hey. It's been good working with Lumis Earrah
- 1:36Speaker 5: Health over the years. It's great to have you back.
- 1:39Speaker 5: The representation that you bring to pharmacists and their profession
- 1:43Speaker 5: in general is pretty important. As someone who's influential. You
- 1:46Speaker 5: made the pharmacy fifty most influential leaders in pharmacy. In
- 1:50Speaker 5: representing the specialty pharmacy space, I think that's important. So
- 1:55Speaker 5: let's right out of the gate, let's talk about influence
- 1:57Speaker 5: for the future. Maybe pharmacies students that are listening in,
- 2:01Speaker 5: but also pharmacists that want to move out of maybe
- 2:03Speaker 5: a retail space and they want to get into specialty
- 2:06Speaker 5: and they really like a specific disease date. Talk to
- 2:09Speaker 5: me about that kind of influence and why that's important.
- 2:11Speaker 6: Yeah.
- 2:12Speaker 4: Absolutely, So, you know, first and foremost, I want to,
- 2:16Speaker 4: you know, give kudos to you for recognizing pharmacists. Really,
- 2:20Speaker 4: what it means to be influential is giving back to
- 2:22Speaker 4: the profession.
- 2:23Speaker 6: That's what I love most.
- 2:25Speaker 4: I had no clue what specialty pharmacy was as a
- 2:29Speaker 4: student at UW Madison and kind of honestly fell into
- 2:34Speaker 4: it a little bit, and through the years have been
- 2:38Speaker 4: lucky enough to learn and grow and see it evolve,
- 2:42Speaker 4: and kind of my commitment and goal has been to
- 2:45Speaker 4: give back to students. I'm a residency program director that
- 2:50Speaker 4: we have a PG Y two leadership program. I feel
- 2:54Speaker 4: like that is a really important aspect to train our
- 2:57Speaker 4: next future pharmacist leaders in specialty pharmacy one because it
- 3:01Speaker 4: didn't really exist in our school and our program at
- 3:05Speaker 4: that time. And now you know, we have the opportunity
- 3:08Speaker 4: to give back. So I love doing that.
- 3:11Speaker 5: Well, that's important, and I like that loumis Earrah Health
- 3:13Speaker 5: pays enough attention to that you were able to come
- 3:16Speaker 5: into Pittsburgh and share kind of some of the story
- 3:18Speaker 5: with us. We had so many students reach out to
- 3:20Speaker 5: us about specialty in general with questions and follow up
- 3:24Speaker 5: you know something that this leads to. So we talked
- 3:26Speaker 5: about advocacy and being represented representing specialty. Right, Well, guess
- 3:31Speaker 5: what that meant something to the point of moving the
- 3:34Speaker 5: needle for Costco to now partner with loumis Era Health.
- 3:38Speaker 5: This is huge, Eric, and I'm so proud of you
- 3:40Speaker 5: guys to talk to us a little bit about how
- 3:42Speaker 5: that came up in the success that that brings.
- 3:45Speaker 4: Yeah, really interesting partnership. Costco has been a partner for
- 3:50Speaker 4: a while now with Navidus, our parent organization, and it's
- 3:54Speaker 4: a real interesting marriage when you look at SSM Health
- 3:58Speaker 4: a health system and then Costco coming together to find
- 4:02Speaker 4: ways to bring value to pharmacy, specialty pharmacy specifically. So
- 4:08Speaker 4: what was really exciting as far as an update this
- 4:10Speaker 4: year is our Lumisarra's integration and partnership with Costco to
- 4:16Speaker 4: provide what Lumis Sarah does is cost plus specialty pharmacy.
- 4:21Speaker 4: We've done that since the day we opened our doors
- 4:23Speaker 4: eleven years ago, and really what we were able to
- 4:27Speaker 4: do now with Costco is bring a name everyone knows
- 4:31Speaker 4: and loves and be able to extend that to more employers,
- 4:38Speaker 4: more patients doing cost plus through that partnership. So it's
- 4:43Speaker 4: been a real win win and we're excited to see
- 4:46Speaker 4: this year we've got close to twenty thousand patients we
- 4:49Speaker 4: expect to have on board and specialty by the end
- 4:52Speaker 4: of the year through this Costco initiative, So we expect
- 4:57Speaker 4: that to just continue to grow and the mark and
- 5:00Speaker 4: the industry is really looking for an appetite of transparency
- 5:03Speaker 4: and we're there to be that solution.
- 5:07Speaker 5: Honestly, you're an innovator and Louis Sarah pays attention to
- 5:12Speaker 5: what's happening, and that means how they're going to pivot
- 5:16Speaker 5: and build programs that help patients where they are and
- 5:19Speaker 5: what disease states that they're dealing with, and the technology
- 5:23Speaker 5: that you're employing and leveraging. So talk about innovation. How
- 5:27Speaker 5: is specialty pharmacy evolving and how's Lumisarah keeping up with
- 5:31Speaker 5: all that?
- 5:32Speaker 4: Yeah, well, I mean it's evolving several ways. I mean
- 5:36Speaker 4: in some regards, I think just our transparent model and
- 5:39Speaker 4: how we do cost plus is innovative. So we as
- 5:44Speaker 4: I was just mentioning, we are seeing and hearing a
- 5:48Speaker 4: lot of patients and employers and health plans that are
- 5:53Speaker 4: calling for a new way to do specialty pharmacy, a
- 5:57Speaker 4: new partnership, and so are our model has been able
- 6:01Speaker 4: to do that. And what's so cool about specialty pharmacy
- 6:04Speaker 4: is that we tend to be early adopters of new
- 6:08Speaker 4: innovative whether it's technology, health tech, or clinical programs. So
- 6:13Speaker 4: being able to extend those to more patients is also
- 6:19Speaker 4: really exciting for us. So we're doing some cool things
- 6:22Speaker 4: with some medtech adherence device clinical programs around that, particularly
- 6:28Speaker 4: in the oncology space, with these extremely high cost medications
- 6:32Speaker 4: that are life saving. So I go back to I'm
- 6:38Speaker 4: just really fortunate and lucky to have kind of fallen
- 6:40Speaker 4: in this field, and my job is really to just
- 6:43Speaker 4: kind of continue to propel those innovative technologies and solutions
- 6:48Speaker 4: to more patients.
- 6:50Speaker 5: Technology that we're hearing a lot about on the ASSEMBIA
- 6:54Speaker 5: twenty twenty five post show is gene and cell therapy
- 6:57Speaker 5: and how that is going to impact the ECO system,
- 7:00Speaker 5: especially disease state management. So loumis aras playing right into
- 7:04Speaker 5: that and I wasn't surprised when I saw this, so
- 7:06Speaker 5: from your team, I was kind of excited. So talk
- 7:09Speaker 5: to us about that facet of the business.
- 7:11Speaker 4: Well, you look at the drug pipeline over the next
- 7:14Speaker 4: five ten years and you're going to see a lot
- 7:17Speaker 4: of gene and self therapies and talk about innovation. These
- 7:20Speaker 4: are in many cases curative treatments now for patients with
- 7:25Speaker 4: debilitating diseases, and being a part of specialty is supporting
- 7:29Speaker 4: those patients, supporting those treatments, being experts in those ultra
- 7:34Speaker 4: rare disease states and so that's really what we want
- 7:39Speaker 4: to be at the front line of that. We've got
- 7:42Speaker 4: amazing patient support to help navigate these patients through getting
- 7:47Speaker 4: access to these treatments. So yeah, we're excited.
- 7:50Speaker 6: That's where we're.
- 7:51Speaker 4: Investing a lot of time and energy because we know
- 7:54Speaker 4: that those treatments are going to be game changers.
- 7:56Speaker 5: Absolutely. We were talking about how do we get pharmacists
- 8:00Speaker 5: to be the hub of healthcare where they have the information,
- 8:02Speaker 5: they have the education, they have the safety protocols, they're
- 8:05Speaker 5: communicating with the physician but giving the data back to
- 8:08Speaker 5: the manufacturer through like a REMS report of some kind.
- 8:11Speaker 5: They're coordinating care, they're helping with finding payment options. Like,
- 8:15Speaker 5: there's so much going on, and that's why in Sembia
- 8:19Speaker 5: is so important. So talk to us about being here
- 8:21Speaker 5: at a Sembia, being a partner of this organization and
- 8:25Speaker 5: being one of the specialty pharmacies that are out front.
- 8:28Speaker 5: You guys are really making waves.
- 8:30Speaker 4: Yeah, well, I haven't missed one in the ten years
- 8:33Speaker 4: that I've been lucky enough to come in it. It's
- 8:37Speaker 4: because you come here and you see all these innovative technologies, solutions, vendors,
- 8:44Speaker 4: and it's really a area where manufacturers pharmacies plans PBMs
- 8:51Speaker 4: are coming and really figuring out how do we solve
- 8:54Speaker 4: the future of specialty pharmacy for our patients. And it's
- 8:59Speaker 4: so collaborative. That's what I love about about a s
- 9:01Speaker 4: MBIA is you're talking with everyone and everyone's looking for
- 9:05Speaker 4: ways to collaborate and and so that's that's why I
- 9:08Speaker 4: love coming and I always walk away learning, learning something new.
- 9:12Speaker 5: Something that would be interesting for me to ask you,
- 9:16Speaker 5: in the position that you've been in because you've seen
- 9:18Speaker 5: it evolve in your career within specialty, how do you
- 9:22Speaker 5: think artificial intelligence is going to what's the biggest impact
- 9:25Speaker 5: that it's going to have on specialty pharmacy specifically in
- 9:28Speaker 5: your opinion?
- 9:29Speaker 4: Well, there's that is a question. You can there's so
- 9:33Speaker 4: much that that AI can do and support and then
- 9:36Speaker 4: obviously needing to to ensure from a you know hipA
- 9:39Speaker 4: and protecting patients that that we do that due diligence
- 9:44Speaker 4: as we're rolling out AI, but AI it will allow
- 9:48Speaker 4: us to bring treatment and access quicker than ever before. Uh,
- 9:55Speaker 4: there is so many complexities when it comes to specialty
- 9:58Speaker 4: pharmacy with costs, with the disease states that we managed
- 10:03Speaker 4: navigating through different specialists and sites of care, and AI
- 10:08Speaker 4: is able to take a lot of the what the
- 10:10Speaker 4: administrative burden that occurs and often causes delays for patients,
- 10:15Speaker 4: and it removes that and it accelerates the time to treatment.
- 10:19Speaker 4: So I think that's where AI and I'm really excited
- 10:22Speaker 4: about where we're looking at incorporating and integrating it as
- 10:26Speaker 4: how does it help us get these treatments in patients
- 10:29Speaker 4: hands Quicker.
- 10:30Speaker 5: Absolutely, Eric, It's been so great spending time with you
- 10:34Speaker 5: here at the show, working with the lumis Era Health team.
- 10:38Speaker 5: Shout out to Barb when her being the rock of
- 10:41Speaker 5: our you know, management of my craziness and running around
- 10:45Speaker 5: every conference, and just shout out to the rest of
- 10:47Speaker 5: your team. Shout out to Ben. Ben couldn't be here
- 10:50Speaker 5: with us at a semi He's he's having FOMO right
- 10:53Speaker 5: now listen to this podcast, but we wanted to shout
- 10:56Speaker 5: out to him. But excited about you coming back. I
- 10:59Speaker 5: want to dive in to some new innovations in products
- 11:03Speaker 5: and disease states Lumisarra Health's working on. I would like
- 11:07Speaker 5: to get some physicians involved in our conversations and do
- 11:09Speaker 5: a collaborative review maybe about a specific disease state and
- 11:13Speaker 5: the challenges that patients are facing in something that you
- 11:16Speaker 5: guys are seeing success in. But thank you so much
- 11:18Speaker 5: for being part of Access to Access to Pharmacy twenty
- 11:21Speaker 5: twenty five.
- 11:22Speaker 4: Well, thank you, tod it' lloyd's pleasure.
- 11:32Speaker 7: Lumisarra Health Services is lighting the way to a healthier you.
- 11:35Speaker 7: As one of the only cost plus specialty pharmacies, lumis
- 11:39Speaker 7: Era is dedicated to providing auditible, lowest net cost prescription pricing,
- 11:43Speaker 7: all while ensuring.
- 11:44Speaker 1: Patients receive the very.
- 11:46Speaker 7: Best possible care. With a patient net promoter score of
- 11:48Speaker 7: eight to five point five, it's easy to see Lumiserra
- 11:51Speaker 7: isn't afraid to take the time necessary with each patient
- 11:54Speaker 7: to listen to their needs, educate them about their therapies,
- 11:57Speaker 7: and foster a caring relationship. Their patient digital engagement platform
- 12:01Speaker 7: has also contributed to the successful outcomes of their patients,
- 12:04Speaker 7: providing simple, easy ways for patients to request refills and
- 12:07Speaker 7: find additional information regarding their condition and lumis Sara is
- 12:11Speaker 7: utilizing their expertise to help build successful solutions for health
- 12:14Speaker 7: system specialty pharmacies by applying the very same pricing and
- 12:18Speaker 7: patient care models. Lumisarra is able to duplicate their processes
- 12:22Speaker 7: to help grow health system specialty pharmacies. To find out
- 12:25Speaker 7: more about lumis Era and see what else they have
- 12:27Speaker 7: going on, go to lumisra dot com.
- 12:33Speaker 8: Hey, this is Dave Griffiths with Access Your Health and
- 12:36Speaker 8: you're listening to their pharmacy podcast.
- 12:38Speaker 5: Yes, Dave, it's great to have you here on Access
- 12:44Speaker 5: twenty five Access to Pharmacy Assembia here in Vegas. Thanks
- 12:48Speaker 5: so much for spending.
- 12:49Speaker 6: Time with me. Oh great to be here. Thanks froscing.
- 12:51Speaker 5: All right, Excess your Health special organization one of our
- 12:55Speaker 5: sponsors last year. We're really appreciative that we've worked with you.
- 12:59Speaker 5: We want to get an update from you. I want
- 13:01Speaker 5: to you know, when I think of what accessia Health
- 13:04Speaker 5: does and assuring that payment is provided for different treatments
- 13:09Speaker 5: and diseases and what people are going through. We can
- 13:11Speaker 5: talk about it from a business perspective. You you know
- 13:16Speaker 5: in the realm that you are Tierra running the organization.
- 13:20Speaker 5: But what I want to do is I want to
- 13:22Speaker 5: hear it from the patient's perspective. I want to hear
- 13:24Speaker 5: what patients here out there about what they're experiencing and
- 13:27Speaker 5: how Eccessy is helping them.
- 13:29Speaker 6: Yeah, it's a great question.
- 13:30Speaker 8: And I think, you know, we were talking earlier offline
- 13:33Speaker 8: about some of the challenges that as an organization obviously
- 13:36Speaker 8: being a nonprofit, and we are limited in the amount
- 13:38Speaker 8: of scope that we can help avoid patients, and we're
- 13:42Speaker 8: always trying to stretch do dollar, like every nonprofit in
- 13:45Speaker 8: America is trying to stretch the dollar even further. But
- 13:47Speaker 8: I think some of the things that we've been hearing
- 13:49Speaker 8: some feedback from patients is it's always great. I mean,
- 13:52Speaker 8: it's wonderful when we go to you know, when you're
- 13:55Speaker 8: at a sembia, it tends to be more especially pharmacy
- 13:58Speaker 8: pharma focus. We go to a lot of advocacy conferences
- 14:01Speaker 8: and we hear directly from patients, and you know, one
- 14:04Speaker 8: of the things that I'm hearing a lot from patients
- 14:06Speaker 8: obviously is that you know, without the assistance of an
- 14:10Speaker 8: organization like Excessior or the other patient assistants organizations that
- 14:13Speaker 8: are out there, these patients don't know where they how
- 14:17Speaker 8: they'd be able to function, and they would not obviously
- 14:20Speaker 8: be able to get their medications or get the support
- 14:22Speaker 8: they need and I think that's something that we try
- 14:25Speaker 8: and communicate not only to our potential pharma donors, but
- 14:28Speaker 8: also other organizations involved in the health space. Those companies
- 14:32Speaker 8: that are making medical devices, companies that are making you know,
- 14:36Speaker 8: support facilities for patients, those are the ones that we're
- 14:42Speaker 8: trying to get that message out there that there is
- 14:43Speaker 8: much more. And one of the things that I tend
- 14:45Speaker 8: to talk about a lot when I'm doing presentations is that,
- 14:48Speaker 8: you know, patients.
- 14:49Speaker 6: Are more than just a prescription.
- 14:51Speaker 8: There's a whole holistic side to what we try and
- 14:53Speaker 8: do with Excessia Health, and that includes providing support for
- 14:58Speaker 8: other out of pocket expenses, not just prescription copay.
- 15:01Speaker 6: And so when you.
- 15:01Speaker 8: Think about the scenario of a patient who needs to
- 15:06Speaker 8: go see a specialist after as a follow up visit,
- 15:09Speaker 8: you know, that's a whole expense for these people to
- 15:11Speaker 8: be able to not only maybe take time off work
- 15:13Speaker 8: or to get from A to B, there's a cost
- 15:16Speaker 8: for them involved, and sometimes they can't really cover that
- 15:19Speaker 8: cost as well as a potential co pay or as
- 15:21Speaker 8: well as some new drugs or you know, other pharmaceuticals
- 15:26Speaker 8: they may need to follow on with that journey. And
- 15:28Speaker 8: so I think what we're finding is that more and
- 15:31Speaker 8: more people are coming to us and the other patient
- 15:33Speaker 8: assistance organizations looking for different types of assistance, Whereas traditionally,
- 15:37Speaker 8: I think maybe ten years ago you would have said
- 15:39Speaker 8: it would have been all copay assistants, And I think
- 15:42Speaker 8: that's a very it's a troubling trend, but it's a
- 15:45Speaker 8: reality that we're having to address.
- 15:47Speaker 5: You know, you've spent some time in the different sectors
- 15:51Speaker 5: of healthcare. Obviously that's how we met through specially pharmacy.
- 15:56Speaker 5: So when you think of the taxing of disease on
- 16:00Speaker 5: a family and what that means, what other services aren't
- 16:05Speaker 5: our specially pharmacists or pharmacies, Like what are they not
- 16:08Speaker 5: thinking about that you're filling in, including things like transportation
- 16:12Speaker 5: and you mentioned a specialists. But talk to us a
- 16:14Speaker 5: little bit more about how important there's ancillary support services are.
- 16:18Speaker 6: Well, you know, I think it start off with one thing.
- 16:20Speaker 8: So in my own story, my wife is a brain
- 16:23Speaker 8: tumor survivor and every month she has to have anti
- 16:27Speaker 8: cazar meds and if she doesn't get them, she would
- 16:29Speaker 8: have a grandma seizure. So I am you know, myself
- 16:32Speaker 8: and my wife are one of those and this is
- 16:35Speaker 8: one of the things when we do talk about patients
- 16:38Speaker 8: and their needs.
- 16:39Speaker 6: You know, we're living it every month.
- 16:41Speaker 8: You know, we turn up the pharmacy and you know,
- 16:44Speaker 8: because it's a controlled substance, we can't reorder her meds
- 16:47Speaker 8: until three days before they expire or before they that
- 16:50Speaker 8: she runs out, and invariably there's going to be some
- 16:53Speaker 8: issue where there's a supply chain issue, or especially Jordan COVID,
- 16:56Speaker 8: we were always worried every month if she was going
- 16:58Speaker 8: to have our meds there. Yeah, And so what I'd
- 17:02Speaker 8: like to say is every single month, myself and or
- 17:04Speaker 8: my wife are standing at a pharmacy counter hoping.
- 17:09Speaker 6: That our meds are there. Okay.
- 17:11Speaker 8: And there was a situation a couple of years ago
- 17:13Speaker 8: where due to COVID and supply chain issues that the CBS.
- 17:17Speaker 8: It's not not against CVS. I'm just saying where the
- 17:19Speaker 8: pharmacy said they didn't have her meds in. They just
- 17:21Speaker 8: didn't have them. And so I said, well, what she's
- 17:23Speaker 8: supposed to do and they're like, we don't really know,
- 17:26Speaker 8: you know. And I say that in contexts is that
- 17:29Speaker 8: every month when I'm there, they are rushed off their
- 17:32Speaker 8: feet there's a constant line of people behind me or
- 17:35Speaker 8: in front of me waiting to get to that pharmacy.
- 17:37Speaker 6: And I find it.
- 17:39Speaker 8: A very stressful job to look at on the other side,
- 17:42Speaker 8: and it makes me think about when a patient comes
- 17:47Speaker 8: to that pharmacist, how is it.
- 17:49Speaker 6: How is all the pressure on the pharmacist. It can't be.
- 17:52Speaker 6: They can't know all the answers. They have so many
- 17:54Speaker 6: things going on.
- 17:55Speaker 8: And we've all been there from a job standpoint where
- 17:57Speaker 8: maybe let's say you have an important presentation to tomorrow morning,
- 18:01Speaker 8: and you've.
- 18:01Speaker 6: Got to get your power point ready. You've got to
- 18:02Speaker 6: get your notes ready. You don't have time for anything
- 18:04Speaker 6: else exactly, you know, whether it's.
- 18:06Speaker 8: Your you know, maybe your family and maybe your friends,
- 18:07Speaker 8: and maybe someone wanting to go out and or somebody
- 18:09Speaker 8: calling you.
- 18:10Speaker 6: I can't talk to you right now. I've got to
- 18:11Speaker 6: concentrate on this.
- 18:12Speaker 8: When you think about a pharmacist, I do, honestly, God,
- 18:15Speaker 8: I have a lot of sympathy for those in our
- 18:17Speaker 8: specialty pharmacies because they're run off their feet and there
- 18:19Speaker 8: are so many other layers to the onion than just
- 18:22Speaker 8: handing someone, you know, a bag of pills. Yep, you know,
- 18:25Speaker 8: so anyway to get back to what I was trying
- 18:28Speaker 8: to get to, I think it's on all of us,
- 18:31Speaker 8: and I mean that honestly. It's pharma, it's specialty pharmacy,
- 18:34Speaker 8: it's advocacy, it's companies who are making products in the
- 18:37Speaker 8: health related field to get the information out there, to
- 18:40Speaker 8: give patients as much information as possible so that they
- 18:43Speaker 8: are aware.
- 18:44Speaker 6: And I'll tell you this.
- 18:46Speaker 8: I've been in nonprofit fundraising, primarily for health charities for
- 18:49Speaker 8: the last twenty plus years.
- 18:51Speaker 6: Until I started with excessive help.
- 18:53Speaker 8: I had no idea there was a patient assistance industry
- 18:57Speaker 8: and my wife for many many years went and you know,
- 19:01Speaker 8: we were lucky enough where we could pay our co pays,
- 19:04Speaker 8: but there was a lot of out of pocket expenses
- 19:06Speaker 8: for her after her surgery. She had a massive brain tumor,
- 19:10Speaker 8: and you know it was without health insurance we would have.
- 19:13Speaker 6: Gone bankrupts not have it paid for that surgery.
- 19:16Speaker 8: But at the end of the day, she's been taking
- 19:18Speaker 8: those meds ever since her brain tumor, and there was
- 19:21Speaker 8: times where we were.
- 19:22Speaker 6: On Cobra and had to pay fall out of pocket.
- 19:26Speaker 8: And you know, these are some kind of things that
- 19:29Speaker 8: patient assistants organizations can help you with. But the other
- 19:32Speaker 8: part of it is is that if one of the
- 19:34Speaker 8: things I found very quickly about brain tumors and about
- 19:38Speaker 8: people who are going through major health issues is that
- 19:42Speaker 8: the support groups are out there, but you have to
- 19:44Speaker 8: find them. And how do you have time to find
- 19:47Speaker 8: these things when you're stressing about paying for your drugs
- 19:49Speaker 8: or paying for access or going.
- 19:50Speaker 6: To doctor's officer or specialist offices.
- 19:53Speaker 8: So farth So, all that being said, I think this
- 19:55Speaker 8: is important for us as an advocacy organization, as a
- 19:58Speaker 8: patient assistants organization. I think it's important for every time
- 20:02Speaker 8: I sit and speak with a farmer representative, it's not
- 20:04Speaker 8: just about me saying, hey, can you fund this program?
- 20:08Speaker 8: It should be about hey, can you fund this program?
- 20:10Speaker 8: And also, by the way, how can we all do.
- 20:12Speaker 6: A better job of assisting patients?
- 20:13Speaker 8: And sometimes the farmer companies you know, well not sometimes.
- 20:18Speaker 8: I know all the people that we talk to on
- 20:20Speaker 8: the farmer side, they're all passionate about the diseases that
- 20:24Speaker 8: they represent and about the therapies where they have a specialty.
- 20:28Speaker 8: And I think there's no doubt that anyone that's involved
- 20:30Speaker 8: in the specially pharmacy side of thing is passionate about patients.
- 20:34Speaker 8: And we just heard you know, Elizabeth Johnson and Melissa Page,
- 20:37Speaker 8: you know, we heard them talk about their their Healthcare
- 20:39Speaker 8: Advocate summit. When you go through those types of summits,
- 20:42Speaker 8: you know everybody there is passionate. Yeah, but I always
- 20:45Speaker 8: say in nonprofit passionate is not enough.
- 20:47Speaker 6: You have to have a strategy. True, and if we can,
- 20:51Speaker 6: we just neem to.
- 20:52Speaker 8: Be more strategic about how we're communicating to patients.
- 20:55Speaker 6: And you know, we heard at the.
- 20:58Speaker 8: Patient Advocacy Summit that was held in Philadelphia a couple
- 21:00Speaker 8: of months ago that I think something like thirty percent
- 21:04Speaker 8: of patients were aware of the IRA and aware of
- 21:06Speaker 8: the smoothing opportunities that they could take advantage of. How
- 21:10Speaker 8: can thirty percent of people seventy percent of people not
- 21:13Speaker 8: know about this, you know? And why is it especially
- 21:16Speaker 8: pharmacy's job to educate patients on that.
- 21:19Speaker 5: I love it. I love the stories that you're sharing.
- 21:22Speaker 5: It really makes connections. Everyone listening to this podcast right
- 21:27Speaker 5: now probably has a friend, a family member, a spouse,
- 21:30Speaker 5: a loved one that has gone through something where it's
- 21:35Speaker 5: placed more pressure and more tax on their lifestyle, on
- 21:40Speaker 5: their budget on their finances and navigating where to go
- 21:44Speaker 5: to make it all make sense. So Accessia Health give
- 21:48Speaker 5: us a shout out. Tell us what web? Tell us
- 21:50Speaker 5: the website where we can learn more about you guys.
- 21:52Speaker 8: Yeah, www dot Excessiahealth dot org dot org. I would say,
- 21:58Speaker 8: say one more thing. Yeah, so I'm originally from Ireland,
- 22:02Speaker 8: so we can gets from the accent.
- 22:03Speaker 5: Yeah, we like the accent.
- 22:05Speaker 8: I spent thirty five years in Kentucky and I haven't
- 22:07Speaker 8: picked up a Kentucky twang yet.
- 22:08Speaker 6: I don't know. But I was home in Ireland in March.
- 22:11Speaker 8: My mother has been diagnosed with breast cancer and it's
- 22:15Speaker 8: spared to her liver, and thankfully she's on the meds
- 22:18Speaker 8: and she seems to be doing okay. But while I
- 22:20Speaker 8: was home, I went to the hospital with her.
- 22:22Speaker 6: Now again, you know, in Ireland we.
- 22:24Speaker 8: Have socialized medicine, so we went to the hospital. You
- 22:27Speaker 8: have to make appointments and sometimes people talk about how
- 22:30Speaker 8: you have to wait six months to go see a
- 22:31Speaker 8: specialist wherever it might be in and that's quite true.
- 22:33Speaker 6: You have to get on a list.
- 22:35Speaker 8: So one thing I noticed Todd was I was sitting
- 22:37Speaker 8: there in the hospital with her in the cancer wing,
- 22:41Speaker 8: and everybody there was either going through treatment obviously had cancer,
- 22:45Speaker 8: some types of cancer, primarily women, and went to see
- 22:50Speaker 8: the specialist and my mother's blood count was a little
- 22:53Speaker 8: bit low, so he said to herself, I'm just going
- 22:54Speaker 8: to send you for a quick scan. Let's go down
- 22:56Speaker 8: the hall and get a quick scan so I can
- 22:57Speaker 8: have a look. And it struck me right there and
- 23:00Speaker 8: then because my mother just got up out of the
- 23:01Speaker 8: chair and walk down the hall and got a scan.
- 23:02Speaker 8: Now Here in the States, what's a patient going to
- 23:05Speaker 8: say if a doctor says, I want to send you
- 23:06Speaker 8: for a quick scan, but first we're going to say
- 23:08Speaker 8: is it covered exactly?
- 23:10Speaker 6: How much is it going to cost me? And then
- 23:11Speaker 6: all this stress you have.
- 23:12Speaker 8: And one thing I really kind of I noticed was
- 23:14Speaker 8: that even though all the people that were there to
- 23:17Speaker 8: be seen were struggling with cancer and struggling with their health,
- 23:21Speaker 8: they didn't have that added stress of how they're going
- 23:24Speaker 8: to pay for it or what's going to happen after I.
- 23:27Speaker 6: Have this scan or this procedure.
- 23:29Speaker 8: And it struck me as that, you know, I know
- 23:31Speaker 8: we can't solve the issue over here. And I'm not
- 23:32Speaker 8: saying we need to have socialized health care in America,
- 23:34Speaker 8: because there are all.
- 23:35Speaker 6: Other conversations you need to have about that.
- 23:37Speaker 8: But it was really interesting to me that in my
- 23:40Speaker 8: mother's story, right now, she can focus on getting better.
- 23:44Speaker 6: That's all she has to focus on.
- 23:46Speaker 8: So she has her pills, she has her therapy, she
- 23:49Speaker 8: has our appointments, and she can go to all of them.
- 23:51Speaker 6: She doesn't have to worry.
- 23:52Speaker 8: About how much it's going to cost or how she's
- 23:54Speaker 8: going to pay for X, Y and z in order
- 23:56Speaker 8: to be able to have this. And that struck me
- 23:58Speaker 8: as being when I came back from that march, and
- 24:00Speaker 8: I came back from that meeting and I said to
- 24:02Speaker 8: myself or from that trip, and I said to myself,
- 24:03Speaker 8: at our meetings, we have to do a better job.
- 24:07Speaker 8: We have to try everything we can to make sure
- 24:09Speaker 8: that every patient that comes to excess your health or
- 24:11Speaker 8: any of these patient assistants organizations can only needs to
- 24:15Speaker 8: focus on healing their body. Take the medications, stay on
- 24:19Speaker 8: the therapies, keep that adherence at one hundred percent.
- 24:22Speaker 6: But that's all you have to worry about.
- 24:24Speaker 8: And so you know, can we can't solve it today,
- 24:27Speaker 8: but yeah, but we can all do a better job
- 24:28Speaker 8: of that and it really it really struck me as
- 24:30Speaker 8: how I think a lot of people if they can
- 24:33Speaker 8: just focus on getting better and I have to stress
- 24:36Speaker 8: true the financial stress, I think it's going to.
- 24:37Speaker 6: Help them an awful lot more.
- 24:39Speaker 8: And that's one of the cruxes that we try and
- 24:42Speaker 8: identifying one of the barriers to care. I think that's
- 24:45Speaker 8: the biggest barrier that we find obviously from patients, is
- 24:47Speaker 8: that it's the cost.
- 24:48Speaker 6: Absolutely.
- 24:49Speaker 5: Dave Griffith, excess your health. Thanks for being part of
- 24:52Speaker 5: the show.
- 24:53Speaker 6: Thanks for having us. Appreciate it.
- 24:58Speaker 5: Harry Travis, Access to Pharmacy twenty twenty five, Assembia, Welcome
- 25:03Speaker 5: to the show.
- 25:04Speaker 9: It is great to be here, Todd. Great to see
- 25:06Speaker 9: you at another Assembia. Just camp eat it.
- 25:10Speaker 5: That's how we meant a shout out to Shavani Patel
- 25:13Speaker 5: and the team and the technology division at ASSEMBIA. In
- 25:16Speaker 5: the creation of Assembia one, you came into a board
- 25:19Speaker 5: room in New Jersey and you really gave us an
- 25:22Speaker 5: overview presentation of where you believed, specially pharmacy was going.
- 25:27Speaker 5: Probably of the ten subjects you were talking about, you're
- 25:29Speaker 5: probably right about ten of the ten of them. In
- 25:33Speaker 5: formulating where it was going but something that you did
- 25:37Speaker 5: here at ASSEMBIA was talk about the impact of artificial
- 25:40Speaker 5: intelligence on specialty pharmacy. And the information that you gleamed
- 25:45Speaker 5: and built in order to prepare for that presentation is
- 25:49Speaker 5: something that the Pharmacy Podcast Network is going to continue
- 25:53Speaker 5: to use, probably over the next three to six months.
- 25:55Speaker 5: So I'm excited about that resource. But congratulations on your presentation,
- 26:00Speaker 5: and I want you to share with our listeners about
- 26:02Speaker 5: what that presentation was about.
- 26:04Speaker 9: Well, thanks, and I was. I am very grateful to
- 26:08Speaker 9: the Assembly of Crowd and the Chris Spends for giving
- 26:10Speaker 9: me the opportunity to give that presentation. We did it
- 26:13Speaker 9: on Monday, which is fun, and we had a I
- 26:16Speaker 9: don't know, four or five hundred people in the room,
- 26:18Speaker 9: so it was great, great turnout. Everybody stayed. That's always
- 26:22Speaker 9: a good indicator of a successful presentation. And what I
- 26:26Speaker 9: tried to do was give everybody in, you know, in
- 26:30Speaker 9: forty minutes a quick overview of some of the highlights
- 26:33Speaker 9: and in AI in general, and how fast the technology
- 26:38Speaker 9: is moving, and how much money is being spent on
- 26:41Speaker 9: the technology, and a lot of the money that's being
- 26:46Speaker 9: spent hasn't even kind of come to fruition. So if
- 26:49Speaker 9: you're not happy with what you're seeing in AI right now,
- 26:53Speaker 9: just wait a few weeks, a few months, and it
- 26:56Speaker 9: will change and it will get better because there's tremendous
- 26:59Speaker 9: kind of innovation momentum going. And then I just talked
- 27:02Speaker 9: about pharmacy and the fact that right now, from a
- 27:06Speaker 9: pharmacy perspective, there are dozens of companies out there, literally
- 27:12Speaker 9: multiple dozens of companies, and small clusters of those three
- 27:17Speaker 9: or four companies each working on automating or optimizing or
- 27:22Speaker 9: accelerating each step in the prescription fulfillment process. We're in
- 27:28Speaker 9: the we're in the beginnings of what I call a
- 27:31Speaker 9: three phase My model is just a three phase move
- 27:36Speaker 9: to a very intelligent pharmacy dispensing application or pharmacy management system.
- 27:42Speaker 9: But right now we're in phase one where we have
- 27:45Speaker 9: to validate all these single point solutions. So you've got
- 27:48Speaker 9: somebody coming to you with a single point solution for
- 27:51Speaker 9: copay assistance, prior authorization DURE. And no matter how big
- 27:56Speaker 9: your pharmacy is, you can only do so many things.
- 27:59Speaker 9: So you're working on one of these to validate it,
- 28:02Speaker 9: somebody else might be working on another one. So the
- 28:05Speaker 9: market is just slowly validating all these single point solutions
- 28:09Speaker 9: to get them to very high levels of reliability six
- 28:13Speaker 9: sigma plus kind of. And then when we're comfortable with
- 28:16Speaker 9: those you start implementing them. You're going to start daisy
- 28:19Speaker 9: chaining them together. And phase two will be kind of
- 28:23Speaker 9: sequential integration. The bot that does the intake will pass
- 28:27Speaker 9: it off to the bot that does the verification or
- 28:30Speaker 9: the agent. That's the new term. Now, the AI agent
- 28:33Speaker 9: will do the benefit verification, then another agent might call
- 28:37Speaker 9: out and confirm delivery or something with the patient, and
- 28:40Speaker 9: then another agent will do a final adjudication, et cetera, etc.
- 28:45Speaker 9: And then eventually all these APIs to all these agents
- 28:48Speaker 9: will just dissolve down. I believe, just one man's opinion.
- 28:52Speaker 9: I believe that we'll all dissolve down into the application,
- 28:56Speaker 9: and your pharmacy application will be incredibly smart and it'll
- 29:02Speaker 9: process a prescription kind of no hands maw, It'll go
- 29:06Speaker 9: right through there. So I'm being a little long winded here,
- 29:11Speaker 9: but the punchline is at the end of this, we're
- 29:14Speaker 9: going to have very productive pharmacy teams, and we need
- 29:17Speaker 9: to be ready for what happens when you're a pharmacy team.
- 29:22Speaker 9: And it's not just a pharmacist, it's the team is
- 29:26Speaker 9: fifty percent more productive. A pharmacy team could get x
- 29:31Speaker 9: amount of work done in eight hours. Now with an
- 29:33Speaker 9: intelligent application, they can get it done in four hours.
- 29:37Speaker 9: And as a leader or owner, you need to be
- 29:40Speaker 9: ready to how am I going to deploy? It's not
- 29:42Speaker 9: going to happen overnight, but it could happen fast.
- 29:45Speaker 6: Yep.
- 29:45Speaker 5: All right, do you remember the buzzword? I don't know.
- 29:49Speaker 5: This has to be more than ten years ago where
- 29:52Speaker 5: they started to talk about predictive analytics. Right, Okay, the
- 29:57Speaker 5: very first thing. Now that we're at the realm and
- 30:00Speaker 5: now we're at the capacity of using AI to sprinkle
- 30:04Speaker 5: things into a chat EPT and all of a sudden
- 30:06Speaker 5: get a whole organized realm of information on something. I
- 30:11Speaker 5: remember going to a specially pharmacy in watching the call
- 30:17Speaker 5: center take specific questions, answers, question answer that was funneled
- 30:22Speaker 5: to the EHR, that was funneled to the pharmacy management system,
- 30:25Speaker 5: so they could track how is someone doing on therapy
- 30:28Speaker 5: day nine or day thirty or day sixty, like, what's
- 30:31Speaker 5: going on? What's going on? So we've collected all this data,
- 30:34Speaker 5: data data. I put all of that data. Let's say
- 30:37Speaker 5: I take a thousand patients over a ten year period
- 30:41Speaker 5: that were some blood disorder right and when they're on
- 30:46Speaker 5: medication ABC. Now we put all this data into AI
- 30:52Speaker 5: and say we want to know, based on one thousand patients,
- 30:56Speaker 5: what their reaction was to the medication on day nine,
- 30:59Speaker 5: on day thirty, and day that's just for patient care
- 31:03Speaker 5: and treatment care. I'm describing something that could be done
- 31:06Speaker 5: with logistics, could be done with inventory management, that could
- 31:10Speaker 5: be done with pharmacy desert analytics and telling us where
- 31:14Speaker 5: the next pharmacy desert's going to pop up. Like it's powerful.
- 31:17Speaker 5: And when you say fifty percent, I think it's going
- 31:20Speaker 5: to be more than fifty percent. I think you're going
- 31:22Speaker 5: to be able to increase your workload by seventy five
- 31:26Speaker 5: one hundred percent.
- 31:27Speaker 9: Depends on the time horizon. You could be right, you know,
- 31:31Speaker 9: and it depends on your workload. You know, are you
- 31:33Speaker 9: doing relatively simple prescriptions and not to oversimplify every Every
- 31:39Speaker 9: prescription is critical regardless of the type of drug. But
- 31:42Speaker 9: some businesses are easier than others, and they will automate
- 31:46Speaker 9: faster than others. So certainly there will be segments of
- 31:51Speaker 9: the pharmacy business that will move to a highly productive
- 31:56Speaker 9: state faster than others.
- 31:58Speaker 6: Yes.
- 32:00Speaker 9: One of the other points I made and the presentation
- 32:02Speaker 9: is remember pharmacy is regulated on a state by state basis,
- 32:06Speaker 9: not a national basis. Therefore, your ability to do something
- 32:11Speaker 9: other than just dispense and council is dependent on how
- 32:15Speaker 9: your Board of Pharmacy regulations are written. And some states
- 32:19Speaker 9: and iPoint everybody to Idaho have really done far reaching
- 32:25Speaker 9: improvements to their Board of Pharmacy regulations and have embraced
- 32:30Speaker 9: what's called full practice authority, so pharmacists can practice at
- 32:35Speaker 9: the top of their license, can dispense or can prescribe,
- 32:39Speaker 9: can order tests, can run a primary hypertension clinic, and
- 32:45Speaker 9: dispense the meds. But that's not the case in Florida.
- 32:49Speaker 9: So this is going it's a patchwork of evolution of
- 32:54Speaker 9: all of these. But we're at an interesting point where
- 32:58Speaker 9: the regulations are moving, hope to a more expansive view
- 33:02Speaker 9: of the practice of pharmacy. At the same time technology
- 33:05Speaker 9: is coming on board that's going to give the pharmacists
- 33:08Speaker 9: time to do that. If you told a bunch of
- 33:09Speaker 9: pharmacists in the states right now, Oh, you could do this,
- 33:12Speaker 9: this and this, and they say when do I have
- 33:13Speaker 9: the time to do that? And then the next battle,
- 33:16Speaker 9: of course, is to make sure they get paid for it.
- 33:18Speaker 9: But before you fight the battle for providers status, you've
- 33:22Speaker 9: got to make sure that from a regulatory status you
- 33:25Speaker 9: can do what you want to get paid for.
- 33:28Speaker 5: It makes sense, That makes sense. So is there any
- 33:31Speaker 5: organization that you see using AI AI in some capacity
- 33:36Speaker 5: that probably was parallel to what you were talking about
- 33:39Speaker 5: at the presentation, that is just doing a bang up
- 33:42Speaker 5: job doing it the right way.
- 33:44Speaker 9: At this point, I don't think there's any one organization
- 33:48Speaker 9: that's out in front of anybody else become a pharmacy
- 33:51Speaker 9: operations standpoint, that's using AI better than anyone else. I'll
- 33:55Speaker 9: call out the Academy Managed Care Pharmacy as an organ
- 33:59Speaker 9: as a organization and association, a professional association that has
- 34:04Speaker 9: embraced AI and recognizes that the profession of pharmacy needs
- 34:10Speaker 9: to have a forum, a curated forum for intelligent discussion
- 34:17Speaker 9: on regulatory issues, ethical issues, operational issues, just a place
- 34:22Speaker 9: one stop shop to go and get that information. So,
- 34:26Speaker 9: Susan Cantrell and her team, are you did that with
- 34:30Speaker 9: a preconference to their annual meeting and now are headed
- 34:33Speaker 9: that way. ASSEMBIA pretty much put put together Monday afternoon
- 34:38Speaker 9: was AI in the Future of Pharmacy my presentation, and
- 34:42Speaker 9: then Jeff Masaros and Shannon Wiley and Lenea Wilson on
- 34:47Speaker 9: regulatory and George van Antwerp on what's even beyond that?
- 34:51Speaker 9: So the beginning of kind of a theme developing here too,
- 34:54Speaker 9: So kudos to ASSEMBIA to seeing it as well.
- 34:57Speaker 5: It's great, Hey, you have something called the RX Roundtable
- 35:01Speaker 5: that you're doing, which is insights sandbox of some amazing
- 35:07Speaker 5: thoughts and topics. Tell our listeners about that.
- 35:11Speaker 9: So the RX Roundtable is an expert network of independent
- 35:14Speaker 9: consultants kind of retired executives, semi retired executives, board advisors.
- 35:20Speaker 9: But the key is it is a professional membership organization
- 35:23Speaker 9: of individuals who are independent, no one is working for
- 35:27Speaker 9: anybody else other than themselves, with deep, deep experience in
- 35:32Speaker 9: all aspects of kind of the pharmacy, distribution and supply chain.
- 35:38Speaker 9: And we offer early stage companies, Series A, series B
- 35:43Speaker 9: companies to come and talk to us about one inform
- 35:47Speaker 9: us of what they've got and to you essentially test
- 35:51Speaker 9: our brains against their market, their challenges to see how
- 35:55Speaker 9: we can help them in kind of a an informal
- 36:01Speaker 9: session that doesn't have any constraints to it. It's no
- 36:04Speaker 9: confidential information, there's nothing involved, but it's just a networking
- 36:08Speaker 9: event that we hold twice a month for individual companies
- 36:12Speaker 9: and then if somebody wants to work with us, great,
- 36:14Speaker 9: But we have really focused our efforts right now on
- 36:17Speaker 9: identifying early stage companies that are in this kind of
- 36:21Speaker 9: farm tech AI powered space, and it's kind of a
- 36:26Speaker 9: matchmaking operation and give them an opportunity to meet people
- 36:29Speaker 9: that they'd never have a chance to meet before. And
- 36:31Speaker 9: kind of the thirty plus years experience and lots of individuals,
- 36:35Speaker 9: it's kind of fun to watch young entrepreneurs connect with us.
- 36:38Speaker 6: I like that, Harry.
- 36:39Speaker 5: It's always good to talk with you. I appreciate you
- 36:42Speaker 5: always making time for us at Assembia and we look
- 36:45Speaker 5: forward to seeing you at Assembia twenty twenty six.
- 36:48Speaker 9: Likewise, thanks for the opportunity and have a great year
- 36:51Speaker 9: between now and Assembia twenty six.
- 36:54Speaker 5: It happens fast, it does.
- 36:55Speaker 9: Bye bye, George.
- 37:02Speaker 5: It's good to have you back. Access twenty five Access
- 37:05Speaker 5: to Pharmacy Assembia here in Vegas, and it's been a
- 37:09Speaker 5: fast twelve months because you were here in twenty twenty four.
- 37:13Speaker 5: Part of the post show.
- 37:14Speaker 10: I was, Yeah, always glad to be on your show,
- 37:16Speaker 10: Todd and talk about stuff. It's asembdas Gronatan.
- 37:19Speaker 5: Over the years it has. I keep saying to people,
- 37:21Speaker 5: I think this is my ninth Assembia and back then
- 37:25Speaker 5: it was Armada Health and this is just in all like,
- 37:30Speaker 5: this is my favorite specialty business show because of how
- 37:34Speaker 5: many people come here to talk business. They're not necessarily
- 37:38Speaker 5: here for clinical they want innovation, they want to meet
- 37:41Speaker 5: with people, they want to know what the next thing is.
- 37:44Speaker 5: Prime Therapeutics is part of that. You're here at Assembia.
- 37:48Speaker 5: Talk to us about your new endeavor and what you're
- 37:51Speaker 5: doing at Prime Therapeutics and kind of a couple of
- 37:53Speaker 5: things that you're excited about.
- 37:55Speaker 6: Yeah, and I'm excited.
- 37:56Speaker 10: I joined Prime about six months ago, leading product in
- 38:00Speaker 10: and strategy and now taking on some of the digital things.
- 38:03Speaker 10: So it's been really fun because, as everybody knows, pharmacy
- 38:06Speaker 10: is going through a ton of transformation, both on the
- 38:08Speaker 10: pay your PBM side with regulation and everything else, but
- 38:11Speaker 10: also on the clinical side with all the innovations happening
- 38:14Speaker 10: from GLP ones to selling gene therapy and others.
- 38:17Speaker 6: So you know, those are probably a couple of the
- 38:19Speaker 6: big areas.
- 38:20Speaker 10: Looking at how we help clients, we always put it
- 38:22Speaker 10: in three buckets, Save, simplify and support. Given the complexity
- 38:26Speaker 10: of healthcare, how do we help the individual member figure
- 38:29Speaker 10: out the right drug, save money, navigate the complexity of
- 38:33Speaker 10: benefits that we all keep putting out there, and support
- 38:35Speaker 10: them because you know, people that get diagnosed with everything
- 38:38Speaker 10: from cardiometabolic to cancer and everything else, it's really difficult
- 38:42Speaker 10: to navigate.
- 38:43Speaker 5: Which you've done for years, George, as you've taken data
- 38:47Speaker 5: that is super complex, data hard to understand, and you've
- 38:50Speaker 5: written your like that pros expert writer where you're able
- 38:54Speaker 5: to take data and you're actually able to tell stories.
- 38:57Speaker 5: So tell our listeners a story right now about Prime
- 39:00Speaker 5: Therapeutics mission. In specialty pharmacy.
- 39:04Speaker 10: Our mission has and always continues to be delivering healthcare
- 39:08Speaker 10: that's the way we would want it for those that
- 39:09Speaker 10: we love. And so as we go out and design specialty,
- 39:13Speaker 10: we understand the complexity. So last year we rolled out
- 39:16Speaker 10: what we call Advocate Plus. So when somebody gets a
- 39:18Speaker 10: new script. We're helping figure out using technology what the
- 39:22Speaker 10: right pharmacy to fill that script is for them. But
- 39:24Speaker 10: then we're also assigning an advocate, a live person that's
- 39:27Speaker 10: helping that person with questions around the benefit, questions about
- 39:31Speaker 10: how to navigate their disease, helping them to take advantage
- 39:36Speaker 10: of the insurance offering that they have. And so, as
- 39:39Speaker 10: you may know, you Prime works primarily for a lot
- 39:41Speaker 10: of the Blue Cross issue plans, but then we also
- 39:44Speaker 10: have some commercial lives and medicare lives that we support.
- 39:48Speaker 5: I think of the role of the pharmacists, it's changing
- 39:53Speaker 5: because of automation AI technology taking away the dispensing part
- 39:59Speaker 5: of it. Glad to see it go, I really am.
- 40:02Speaker 5: I'm glad to see that automation and tech is taking
- 40:05Speaker 5: that away because the pharmacists can dial into what that
- 40:09Speaker 5: patient is experiencing, whether it's something super simple or something
- 40:13Speaker 5: a lot more complex. And that's the world that we're
- 40:15Speaker 5: in right now, which is these complex diseases that have
- 40:18Speaker 5: to be monitored and ti trait from one medication to another,
- 40:22Speaker 5: or telling them how to deal with day nine nausea
- 40:25Speaker 5: or whatever it is that they're going through. It's that
- 40:27Speaker 5: pharmacist that's dial dial dialing in, including getting around the
- 40:32Speaker 5: payment issues or copay issues or anything like that. Share
- 40:36Speaker 5: with us some of the data, because once again you
- 40:40Speaker 5: have that interesting scope where you dial into data and
- 40:44Speaker 5: start making sense of it. But talk to us about
- 40:47Speaker 5: things that are happening in especially from your perspective, prime
- 40:51Speaker 5: they peutics perspective, to make this whole ecosystem easier for
- 40:56Speaker 5: the patient, physician and pharmacist experience.
- 41:00Speaker 10: Yeah, and I'm going to tackle that two ways, because
- 41:01Speaker 10: I do think one, you continue to see the growth
- 41:04Speaker 10: rate and specialty you know, really exceed everything else, with
- 41:07Speaker 10: the exception.
- 41:07Speaker 6: Perhaps of GLP ones.
- 41:09Speaker 10: I think there's fascinating things happening on the biosimilar path.
- 41:13Speaker 6: If you look at some.
- 41:13Speaker 10: Of the IQVA data, you know they forecast one hundred
- 41:16Speaker 10: and eighty nine billion in savings from biosimilars over the
- 41:19Speaker 10: next decade. But the more interesting thing I find is
- 41:21Speaker 10: they set this range up. I want to say, it
- 41:23Speaker 10: goes from forty five billion to three hundred and forty
- 41:26Speaker 10: three hundred and fifty billion. And the question is how
- 41:29Speaker 10: do we as a PBM, we as a payer, we
- 41:32Speaker 10: working with the retail pharmacies and pharmacists create the get
- 41:36Speaker 10: us to the high end of that range, because the
- 41:38Speaker 10: question is, how do we build a durable biosimilar market,
- 41:41Speaker 10: How do we enable consumers to understand biosimilars, How do
- 41:45Speaker 10: we help physicians to understand when it's appropriate to feel comfortable.
- 41:49Speaker 6: Moving to the biosimilar.
- 41:50Speaker 10: I think that's a really important topic that we're spending
- 41:53Speaker 10: a lot of time on because we want to open
- 41:55Speaker 10: up opportunity. Some people view it as a negative challenge
- 41:59Speaker 10: to the innovator products, but I view it as opening
- 42:02Speaker 10: up dollars to be spent on innovation and too, because
- 42:06Speaker 10: there's only a finite pool of benefit money to be spared,
- 42:09Speaker 10: and so how do we lower costs where it's appropriate.
- 42:12Speaker 6: And spend the money on some of the innovations that
- 42:14Speaker 6: we need here?
- 42:15Speaker 5: Well, I agree with you, and it's the pharmacists that
- 42:17Speaker 5: you're teaching. It's the physicians that you're teaching, so they
- 42:20Speaker 5: can convey that to the patient that's sitting in front
- 42:23Speaker 5: of them. And when I think of the pharmacists, it's
- 42:26Speaker 5: that the patient trusts that pharmacist to tell them what's
- 42:29Speaker 5: going on. So if we can educate who's listening right now,
- 42:33Speaker 5: and they have questions what's coming up down that ecosystem
- 42:37Speaker 5: of I think of gene and cell therapy and biosimilars
- 42:40Speaker 5: and all the interactions. Talk to it. Give us a
- 42:43Speaker 5: little highlights of what prime therapeutics is discovered in this space.
- 42:48Speaker 6: Yeah, I think there's a couple of things happening there.
- 42:49Speaker 10: I mean, let's just spend a second on the pharmacists,
- 42:52Speaker 10: because I do think that's going to radically change here.
- 42:54Speaker 10: I'm excited about the whole cost plus. I think some
- 42:56Speaker 10: people worry about it. But if we can get to
- 42:59Speaker 10: a true cost plus model that pays a fair dispensing
- 43:02Speaker 10: fee of the pharmacist, and we can get to a
- 43:03Speaker 10: point where that allows us to actually reimburse their cognitive services,
- 43:08Speaker 10: it gets rid of the issue that exists and creates
- 43:10Speaker 10: a ton of the tension today between the pharmacist and
- 43:13Speaker 10: the PBM, which is all these you know, points of
- 43:18Speaker 10: yeah disconnect where we've created a model that subsidizes you know,
- 43:23Speaker 10: generic subsidize the brands, and so you create all these
- 43:25Speaker 10: anomalies where people can come in and say, oh my god,
- 43:28Speaker 10: look how much you're paying over here. When we can
- 43:30Speaker 10: get to a fair reimbursement model where there's not you know,
- 43:33Speaker 10: high margin here and low margin there. We can then
- 43:36Speaker 10: begin to say to the pharmacist, all right, how do
- 43:38Speaker 10: I give you the right data at the point of
- 43:41Speaker 10: sale where you can use that to talk to the patient.
- 43:44Speaker 10: How do I help you understand how to guide them
- 43:48Speaker 10: to the right therapy, how to help them understand their diseases?
- 43:52Speaker 6: And I think, you know, in a perfect.
- 43:53Speaker 10: World, I was talking to somebody earlier today about years
- 43:56Speaker 10: and years ago when I was at Express we would
- 43:58Speaker 10: get prescriptions, and one stuck in my head where the
- 44:00Speaker 10: doctor just wrote fill with PPI like they weren't picking
- 44:04Speaker 10: the drug. They were allowing the pharmacists to pick the drug.
- 44:07Speaker 10: They were doing the diagnosing. And I think in a
- 44:09Speaker 10: future world for me, where we get to physicians diagnosing
- 44:13Speaker 10: and in some cases, yes, they're still going to pick
- 44:15Speaker 10: the drug in really complex because there's so many opportunities
- 44:18Speaker 10: for the pharmacists to play a much more active role
- 44:20Speaker 10: in getting the right drug for the patient, helping understand
- 44:24Speaker 10: their benefit design, talking to them at the counter or digitally,
- 44:28Speaker 10: and guiding them and following the right care pathways. And
- 44:31Speaker 10: I think specialty is where we're going to see that
- 44:33Speaker 10: precision medicine really take off, and so thinking about how
- 44:37Speaker 10: you use pharmacogenomics and testing in the store, how you
- 44:41Speaker 10: enable home tests, how the pharmacist can interpret the test,
- 44:45Speaker 10: how you use that in the adjudication process. I'm not
- 44:49Speaker 10: quite sure we're there yet, but I do think in
- 44:50Speaker 10: the next five years that hopefully we get them.
- 44:53Speaker 5: Well, what you're describing is precision medicine. People want to
- 44:56Speaker 5: use that as a buzz term sometimes, but it literally
- 44:59Speaker 5: is being much more sniper rifle like where you're drilling
- 45:03Speaker 5: down into that specific patient's experience and you're putting data
- 45:07Speaker 5: and digital health and tools and AI around that whole
- 45:11Speaker 5: entire environment, which makes it it makes it feel simple
- 45:15Speaker 5: to the patient. All right, I just got done talking
- 45:17Speaker 5: with doctor first, and instead of having an app, they're
- 45:20Speaker 5: just using text and they're communicating text and gathering data
- 45:24Speaker 5: text text, and the text is all that information is
- 45:26Speaker 5: getting sucked up to the HR so they can track
- 45:28Speaker 5: what's going on. Like that makes sense. That's where patients are.
- 45:31Speaker 5: They don't want to deal with a bunch of the
- 45:33Speaker 5: other things that are doing because to them, it just
- 45:35Speaker 5: makes it that's much more complicated. Talk to us before
- 45:39Speaker 5: you go. One more thing, about digital health in particular,
- 45:43Speaker 5: and how Prime Therapeutics has embraced that.
- 45:46Speaker 10: Yeah, so I would say, you know, we're still earlier
- 45:48Speaker 10: than I'd like to be after joining, but you know,
- 45:50Speaker 10: we're really setting a comprehensive strategy that says, let's think
- 45:53Speaker 10: about the jobs to be done digitally and think about
- 45:57Speaker 10: the consumer. Yeah, what do you want as a consumer?
- 45:59Speaker 10: I just want to stam, what does it mean to
- 46:01Speaker 10: get diagnosed? How do I save money on my drugs?
- 46:04Speaker 10: What does my benefit cover? I want, Like you were
- 46:07Speaker 10: just talking about text messaging, I want an easy way
- 46:09Speaker 10: to interact, whether that's chatbot, whether it's voice. Some people
- 46:13Speaker 10: love just sue talking to a Google Home or something
- 46:16Speaker 10: like that. I think same with physician and pharmacists. They
- 46:19Speaker 10: want you to put the stuff into the workflow. So
- 46:21Speaker 10: put it in the MR, put it at the counter.
- 46:24Speaker 10: I don't want to go to a bunch of different
- 46:26Speaker 10: apps or screens. I want to be nudged at the
- 46:29Speaker 10: right time with the right data that says, hey, Todd's
- 46:31Speaker 10: at the counter, and guess what you know, Todd has
- 46:34Speaker 10: this other opportunity and we're willing to pay you ten
- 46:37Speaker 10: dollars to.
- 46:38Speaker 6: Address that gap with him. You know, so how do
- 46:40Speaker 6: we get there digitally?
- 46:41Speaker 10: What does that look like from real time benefit check
- 46:44Speaker 10: from EMR integration, and then you'll follow that all the
- 46:48Speaker 10: way through to the caregiver to the client so they
- 46:50Speaker 10: can see the value that's being created and.
- 46:53Speaker 6: So all those things.
- 46:54Speaker 10: So really right now, trying to take that broad you know,
- 46:56Speaker 10: digital strategy across all those things and put that story
- 46:59Speaker 10: together and then figure out the right foundational data and
- 47:04Speaker 10: technology that's going to make that happen.
- 47:06Speaker 5: George, We appreciate you being part of this. Always want
- 47:10Speaker 5: your insights. Can't wait to have you back on the show.
- 47:13Speaker 5: Got to come back more often than just ascenbi you Yeah, yeah,
- 47:16Speaker 5: I look forward to it. Tob all right, thanks, thank you.
- 47:37Speaker 7: We hope you're enjoying this exclusive coverage of assembia's Access
- 47:40Speaker 7: to Pharmacy conference in Las Vegas. It's time for your
- 47:42Speaker 7: favorite part of the show, Pharmacy Trivia. What drug is
- 47:46Speaker 7: used to treat angina and is also used in making explosives?
- 47:50Speaker 7: Think you got it? If you said nitroglycerin, you're right now.
- 47:54Speaker 7: Don't go looking up how to make explosives with it,
- 47:56Speaker 7: or you'll probably end up on a government watch list.
- 48:02Speaker 5: Hey, here with Chuck Collins with Healthcare Stakeholder Solutions. Chuck,
- 48:06Speaker 5: it's great to run into you at Access twenty five
- 48:09Speaker 5: Access to Pharmacy twenty twenty five.
- 48:11Speaker 11: Yeah, great to be here.
- 48:13Speaker 5: All right. So you had a presentation that I want
- 48:15Speaker 5: to jump right into talk to us about what you
- 48:18Speaker 5: were talking about and why it's so important in the
- 48:21Speaker 5: realm of specialty pharmacy.
- 48:23Speaker 1: Well, so the top.
- 48:25Speaker 11: That we talked about was really around the IRA and
- 48:28Speaker 11: the impact of the Part D benefit redesign and the
- 48:33Speaker 11: Medicare prescription payment program.
- 48:35Speaker 1: And really we took a.
- 48:37Speaker 11: Multi stakeholder approach, so I actually moderated this session and
- 48:40Speaker 11: I had representation from Orsen Specialty Pharmacy from that end,
- 48:45Speaker 11: the Health Well Foundation as well as IMMAPTA, which is
- 48:48Speaker 11: a medication access patient advocacy group. So you've got all
- 48:52Speaker 11: these different stakeholders and we're looking at the impact of
- 48:55Speaker 11: the Medicare Part D benefit redesign for twenty twenty five
- 48:59Speaker 11: which went into place, and then this new payment option.
- 49:03Speaker 11: So one would say is a payment option should be
- 49:05Speaker 11: pretty simple, right, Unfortunately CMS has made this rather complicated,
- 49:11Speaker 11: comprehensive and actually very obtuse, if you will. But it
- 49:15Speaker 11: impacts everyone, and so we talked about the health plan
- 49:18Speaker 11: impact of all this, but especially pharmacy actually is one
- 49:22Speaker 11: that once they're notified that somebody would actually be likely
- 49:27Speaker 11: to benefit. That's the term they use, the official term
- 49:30Speaker 11: is likely to benefit from this payment option. Pharmacists have
- 49:34Speaker 11: the duty to actually inform the patient right on the
- 49:37Speaker 11: spot that you might be eligible for this program. They
- 49:40Speaker 11: don't actually do any education on it, but they give
- 49:43Speaker 11: them a brochure for them to go think about it,
- 49:45Speaker 11: talk to their health plan, and maybe sign up for
- 49:46Speaker 11: this program. If they do sign up for this program,
- 49:50Speaker 11: the pharmacy from that point on collects zero dollars.
- 49:53Speaker 6: On the next prescription.
- 49:54Speaker 11: It's actually going to be taken care of by the
- 49:57Speaker 11: health plan, and the health plan is going to reimburse
- 49:59Speaker 11: back to the pharmacy. So all of a sudden, you've
- 50:01Speaker 11: got a Medicare beneficiary, sign up for MPPP, and they
- 50:06Speaker 11: pick up the drug and so the perception is, oh,
- 50:08Speaker 11: the drug's free because they're not going to get an invoice,
- 50:10Speaker 11: which is a very different thing. We're going to get
- 50:12Speaker 11: an invoice a bill if you will, a month later
- 50:15Speaker 11: from their health plan. Again, another behavioral piece to this
- 50:18Speaker 11: that they're not used to getting. Usually they get eobs
- 50:22Speaker 11: cob saying here's your evidence, a bit of coverage, and
- 50:25Speaker 11: now they're going to say this is an invoice and
- 50:28Speaker 11: you need to pay it. So there's a lot of
- 50:29Speaker 11: moving parts behind this operationally. And then you have the
- 50:33Speaker 11: Healthwell Foundation from a charitable foundation perspective, really looking at, okay,
- 50:38Speaker 11: we have funds to help folks, so maybe talk to
- 50:41Speaker 11: us first before you sign up for this program. We
- 50:43Speaker 11: might actually have enough fund that's open that we can
- 50:45Speaker 11: be able to help that therapeutic carrea and you can
- 50:48Speaker 11: bypass even doing this process.
- 50:52Speaker 5: How has the report identified how multiple stakeholders working together
- 51:00Speaker 5: with these strategies to make up for Medica Medicaid, medicare
- 51:05Speaker 5: part B as in boy or D as in dog
- 51:08Speaker 5: d D isn't X right medicare part D? So how
- 51:12Speaker 5: how have they worked together to bring this to fruition
- 51:15Speaker 5: that we have the report now?
- 51:17Speaker 11: So what's interesting is that the latest data just came
- 51:20Speaker 11: out and it's saying it's not really working well unfortunately.
- 51:24Speaker 11: So there are sixty six sixty seven million people in
- 51:27Speaker 11: our country that have Medicare. Out of that fifty million,
- 51:31Speaker 11: five zero fifty million actually have this benefit designed for
- 51:34Speaker 11: Part D and the thing is under the law. In
- 51:38Speaker 11: with this this piece, Health Plans had to actually communicate
- 51:43Speaker 11: to all fifty million people they have this new payment
- 51:45Speaker 11: option they could smooth their payments out of their maximum
- 51:48Speaker 11: two thousand dollars. So it say it's not working well
- 51:51Speaker 11: because the report just came out in only one hundred
- 51:54Speaker 11: and seventy nine thousand beneficiaries have actually signed up for
- 51:57Speaker 11: this program.
- 51:58Speaker 5: So that tells us there's.
- 52:00Speaker 11: A lack of education, there's a lot of communication and
- 52:04Speaker 11: a lack of coordination as well.
- 52:06Speaker 6: Well.
- 52:07Speaker 5: That reminds me of the pharmacist who's being contacted by
- 52:12Speaker 5: their people and patients nine times more than the physician.
- 52:16Speaker 5: So I think that there's a big opportunity to embrace
- 52:19Speaker 5: our specialty pharmacies, our community pharmacies, even our long term
- 52:23Speaker 5: care groups to get the information out there. I'd like
- 52:27Speaker 5: to do some additional interviews with you around this research
- 52:32Speaker 5: and then like you've done, bringing stakeholders together to talk
- 52:35Speaker 5: about what's their piece in this, to participate in an
- 52:39Speaker 5: ecosystem that we're bringing more information to our patients and
- 52:42Speaker 5: letting them know what's accessible and how to get their
- 52:45Speaker 5: medications paid for.
- 52:46Speaker 11: Yeah, no, that would be excellent. And I'll tell you
- 52:48Speaker 11: one of the quotes that we had from panelists has said,
- 52:50Speaker 11: you know, a year ago, we had about two hundred
- 52:53Speaker 11: questions trying to figure out how all of this is
- 52:55Speaker 11: going to work and operationalize and work together. And she said, today,
- 53:00Speaker 11: I still have one hundred and eighty nine questions that
- 53:02Speaker 11: we've yet not answered.
- 53:04Speaker 1: So it just tells you where we're all at.
- 53:06Speaker 11: And you know, we had a standing room only session
- 53:09Speaker 11: today which was fantastic. A lot of people came up
- 53:11Speaker 11: afterwards wanting the slides, wanting you know, to really understand
- 53:15Speaker 11: and breaking all this down. So there's a lot of
- 53:17Speaker 11: interest around this topic and we need to address it
- 53:20Speaker 11: because it's not going away.
- 53:21Speaker 6: It is here.
- 53:22Speaker 5: Chuck Collins, thanks so much for being part of the
- 53:25Speaker 5: Access twenty five post show. We're excited to see you
- 53:29Speaker 5: and connect with you, and thanks for your insights.
- 53:32Speaker 11: Yeah, my pleasure.
- 53:37Speaker 5: Talk to me about specially pharmacy at any time in
- 53:40Speaker 5: my life and career, my twenty year career in pharmacy.
- 53:45Speaker 5: And if Shila Arcuatt isn't there, I think there's something missing.
- 53:49Speaker 5: Welcome to the show.
- 53:50Speaker 1: Thanks so much, Todd, But that's true. I guess if
- 53:53Speaker 1: you say so.
- 53:54Speaker 5: Oh listen, my career and your career are very similar
- 53:58Speaker 5: in how we've tracked and all the people that we
- 54:00Speaker 5: knew in the beginning of how you started to really
- 54:03Speaker 5: become an executive leader in specialty pharmacy and all of
- 54:06Speaker 5: the investment that you've made back into the industry to
- 54:09Speaker 5: make sure that you're empowering pharmacists specifically and specially pharmacy.
- 54:15Speaker 5: And I can only imagine the stress of kind of
- 54:17Speaker 5: like the ecosystem, what you've got to do as someone
- 54:20Speaker 5: that's kind of leading the NASB, the National Association of
- 54:24Speaker 5: Specially Pharmacies. But I'm proud of it because you're assuring
- 54:28Speaker 5: us that there's some standard set, there's certifications involved, there's criteria,
- 54:34Speaker 5: and you're staying ahead of it so that when the
- 54:36Speaker 5: regulators come along, you're like, we already got that covered.
- 54:40Speaker 5: And I think that's the important of association.
- 54:43Speaker 2: Absolutely, And I think it's more than just the pharmacist
- 54:46Speaker 2: and the pharmacists and the pharmacies and the pharmacy technicians
- 54:49Speaker 2: are so important, but it's all the stakeholders, right, I mean,
- 54:51Speaker 2: even the role that you play and keeping all of
- 54:54Speaker 2: the stakeholders connected. We need to understand what we're all doing,
- 54:57Speaker 2: the role that we play. I always tell people takes
- 55:00Speaker 2: a village to manage a specialty pharmacy patient.
- 55:02Speaker 1: It really does. It's so complicated, right.
- 55:05Speaker 2: And these patients are often facing such devastating diagnoses, such
- 55:09Speaker 2: a challenging time.
- 55:11Speaker 1: They need to lean on all of these folks.
- 55:13Speaker 5: So the public is hit by a lot of good
- 55:16Speaker 5: information bad information, and then of course the Internet lights
- 55:20Speaker 5: it on fire and TikTok, and I mean, I see
- 55:24Speaker 5: there's so many other social platforms coming out. You and
- 55:27Speaker 5: I have talked about this before, but just in case
- 55:29Speaker 5: the listeners haven't heard us talk about this. When I
- 55:33Speaker 5: hear big prominent figures who are doing wonderful things, Mark Cuban,
- 55:37Speaker 5: he's doing some crazy things in pharmacy, right. However, every
- 55:42Speaker 5: time that man talks about specialty pharmacy, he plascifies it
- 55:47Speaker 5: as a PBM trick of Oh, it's called specialty pharmacy
- 55:52Speaker 5: because they want to charge more. And if that man
- 55:55Speaker 5: shout out to you, Mark Cuban, if he just attend
- 55:58Speaker 5: one or two of our comp an nasp An Assembia
- 56:01Speaker 5: conference and come in and understand holy crap like disease
- 56:06Speaker 5: state management in a rare disease where day day, five day,
- 56:12Speaker 5: thirty day, six months on the same medication is putting
- 56:16Speaker 5: your family in a completely different environment than you being
- 56:20Speaker 5: on antibiotic well, right, tod And it's even before all
- 56:25Speaker 5: of that, right, even getting on the drug, the care
- 56:27Speaker 5: coordination that special Depharmacy provides.
- 56:29Speaker 1: I take very big issue with.
- 56:31Speaker 2: Him saying special de pharmacy isn't special.
- 56:33Speaker 1: Because yes, it is.
- 56:35Speaker 2: Right, even from you know, the start we get there,
- 56:37Speaker 2: you know, you get in the prescription referral, We're looking
- 56:39Speaker 2: at benefits. Do these folks have coverage?
- 56:41Speaker 8: Right?
- 56:41Speaker 2: Does the patient have coverage? What does that look like?
- 56:44Speaker 2: Is there a prior authorization required? How do we work
- 56:46Speaker 2: through that? You know, is that approved? Is it denied?
- 56:49Speaker 2: How do we process that denial? And then affordability?
- 56:53Speaker 9: Right?
- 56:53Speaker 1: Can the patient after we go through all of this.
- 56:55Speaker 2: We get it in place, we get it covered, We're
- 56:56Speaker 2: ready to dispense.
- 56:57Speaker 1: Can they afford it?
- 56:58Speaker 4: No?
- 56:58Speaker 1: Okay, Now where do we look for that assistance?
- 57:01Speaker 5: Right?
- 57:01Speaker 2: And then you're right, then we start down that journey
- 57:03Speaker 2: of looking at what medications are you on? What were
- 57:05Speaker 2: you just diagnosed with How does this all come together?
- 57:08Speaker 2: How do we get you on this therapy, how do
- 57:09Speaker 2: we keep you on the therapy, mitigate side effects.
- 57:12Speaker 1: Check back in with you? And it's all individualized, right.
- 57:14Speaker 2: Patients all have a different level of appreciation of their disease,
- 57:18Speaker 2: the drug, what they're doing, how to take it. So
- 57:20Speaker 2: you have to be able to be flexible and customized.
- 57:22Speaker 2: It is special.
- 57:23Speaker 5: It is my favorite part of especially pharmacy, are the
- 57:27Speaker 5: pharmacists who become the maven experts in the specific disease state. Absolutely.
- 57:33Speaker 5: Those pharmacists are like on the phone with the patient
- 57:36Speaker 5: or the patient's caregiver, probably because the patient's sick and sleeping,
- 57:41Speaker 5: and they're like, hey, you've been on this medication for
- 57:44Speaker 5: seven days on a scale from one to ten, What
- 57:46Speaker 5: did Mary your mom tell you her nausea level was?
- 57:50Speaker 5: Was it a seven? Right? Actually it was a seven?
- 57:53Speaker 5: How Like they know it because they've helped hundreds thousands
- 57:57Speaker 5: of patients on the same disease, disease dialing in to
- 58:01Speaker 5: make things more precision and more accurate and more caring
- 58:06Speaker 5: and more empathetic. And you can't get that. I love you,
- 58:10Speaker 5: know me and pharmacists. I love my community pharmacists, who
- 58:14Speaker 5: are even our chain community pharmacists, but they're rolling through
- 58:18Speaker 5: a thousand times more prescriptions that are all over the map,
- 58:22Speaker 5: versus the oncology medication that dials into a lifestyle that
- 58:27Speaker 5: you now have to shift your life the way that
- 58:30Speaker 5: you're living, Versus the person who just got a xyz
- 58:34Speaker 5: met or or an antibiotic because something that's just temporary.
- 58:39Speaker 2: Right, in our community pharmacists, they're doing more than just
- 58:41Speaker 2: dispensing medications as well.
- 58:43Speaker 1: Right, we're testing, we're treating, we're immunizing.
- 58:46Speaker 2: Right, they're providing consultation on over the counter products. Right,
- 58:50Speaker 2: They're pulled in a million different directions. So you're right,
- 58:52Speaker 2: And I think specialty pharmacy it's just unique.
- 58:54Speaker 1: And that they have that infrastructure.
- 58:57Speaker 2: Right, and the business model allows for them to be
- 59:00Speaker 2: those experts in those you know, I guess more rare
- 59:03Speaker 2: type conditions or intricate, right, or just it just involves
- 59:09Speaker 2: a little bit more handholding for that patient, or a
- 59:11Speaker 2: lot more handholding really, But and you know, I don't
- 59:16Speaker 2: ever want any pharmacists to feel that, oh, you know,
- 59:19Speaker 2: these folks are better.
- 59:20Speaker 1: We're not saying that, right, It's just different, different, hospital.
- 59:23Speaker 2: PHARMACI is different from this from long term care, but
- 59:25Speaker 2: we also play a role and I think again, you know,
- 59:27Speaker 2: one of the most trusted healthcare professionals inaccessible.
- 59:31Speaker 6: Yeah.
- 59:31Speaker 5: Right, So NASP twenty twenty five is coming. It's going
- 59:35Speaker 5: to be here before we know it. It's in Denver, Colorado.
- 59:39Speaker 5: I cannot wait. I'm so excited. We're going to be
- 59:41Speaker 5: there supporting the National Association, especially pharmacies. Talk to us
- 59:46Speaker 5: and give us as much as you can without giving
- 59:48Speaker 5: away the secrets. Give us some of the things that
- 59:51Speaker 5: are that are coming from NASP twenty twenty five.
- 59:54Speaker 2: Sure, so we're really excited as well.
- 59:56Speaker 1: The response this year has been overwhelming.
- 59:58Speaker 2: Last year we had you know, we broke records, which
- 1:00:00Speaker 2: was great, and so this year people really you know,
- 1:00:03Speaker 2: they showed up in forced when registration opened, so that
- 1:00:06Speaker 2: that kind of takes a little bit of pressure off
- 1:00:07Speaker 2: of me. But yeah, we're planning again. The first day
- 1:00:11Speaker 2: of the conference, which is on Sunday, September fourteenth, is
- 1:00:13Speaker 2: our workshop day, right, so we have six really focused
- 1:00:16Speaker 2: days of learning these workshops. But what we started last
- 1:00:20Speaker 2: year is a little bit different is you know, we
- 1:00:23Speaker 2: ask folks please sign up for a primary workshop, but
- 1:00:25Speaker 2: then throughout the day you can go in and out
- 1:00:27Speaker 2: of the other ones.
- 1:00:27Speaker 4: Right.
- 1:00:28Speaker 1: Let's say you know you.
- 1:00:29Speaker 2: Signed up for this year we have a new one
- 1:00:31Speaker 2: the Art of Infusion, but you see something over in
- 1:00:33Speaker 2: Specialty Pharmacy Law or in next Gen Intelligence, which is
- 1:00:37Speaker 2: our technology, and you want to scoot over there, and
- 1:00:39Speaker 2: then you can scoop back, right, So people can really
- 1:00:41Speaker 2: customize that day based on what's important to them. And
- 1:00:44Speaker 2: then the main conference starts Monday through Wednesday.
- 1:00:48Speaker 1: And we're doing all the things that we normally do.
- 1:00:50Speaker 4: Right.
- 1:00:51Speaker 1: Our keynote speakers, we have, you.
- 1:00:52Speaker 2: Know, a motivational, inspirational type speaker is also going to
- 1:00:56Speaker 2: do a communication session for leaders. Right, So we're focused
- 1:01:01Speaker 2: a little bit more this year and trying to incorporate
- 1:01:03Speaker 2: some business sessions because we know we have a lot
- 1:01:05Speaker 2: of executives who attend who aren't as interested maybe in
- 1:01:09Speaker 2: the clinical components because they have teams for that.
- 1:01:11Speaker 1: They don't need CE. But geez, how do I be
- 1:01:13Speaker 1: a better leader?
- 1:01:13Speaker 4: Right?
- 1:01:14Speaker 2: What should I be doing? So we're focusing on that.
- 1:01:16Speaker 2: We have our industry awards, our Specialty Women in Specialty
- 1:01:20Speaker 2: Pharmacy luncheon, like we do We also have an event
- 1:01:22Speaker 2: called our Educate to Cultivate where we're going to learn
- 1:01:25Speaker 2: something fun about you know, Colorado and Denver, and it's
- 1:01:28Speaker 2: also a luncheon type atmosphere and have a little bit
- 1:01:30Speaker 2: of fun.
- 1:01:30Speaker 1: We have a big party Tuesday night. The Gaylord in Denver.
- 1:01:34Speaker 2: Is pretty cool because there's a lot of activities that
- 1:01:36Speaker 2: can be done outside. It's a beautiful time of year,
- 1:01:38Speaker 2: so we're going to get outside as much as possible
- 1:01:40Speaker 2: and have a little fun. So, you know, educational sessions
- 1:01:44Speaker 2: all throughout the day, wellness activities, opportunity to network, to
- 1:01:48Speaker 2: connect right and just talk about how do we make
- 1:01:50Speaker 2: patient care better.
- 1:01:51Speaker 6: That's awesome.
- 1:01:52Speaker 5: That's awesome. You gave me before we started the interview.
- 1:01:56Speaker 5: You kind of gave me some insights that NASP is
- 1:01:59Speaker 5: starting to span and your focus and assistance to Canada,
- 1:02:04Speaker 5: which is an important part in North America. Our neighbors
- 1:02:07Speaker 5: and trusted providers of some amazing medisca and I think
- 1:02:13Speaker 5: of all these companies that are from our neighbor of
- 1:02:16Speaker 5: the North. So talk to me about that kind of expansion.
- 1:02:19Speaker 1: Sure.
- 1:02:19Speaker 2: So we've always offered our certified specialty pharmacist credential to
- 1:02:24Speaker 2: our friends in Canada. But I have some colleagues and
- 1:02:28Speaker 2: some friends who live in Quebec who had approached me
- 1:02:31Speaker 2: about a certificate program for specialty pharmacists in Canada. Right
- 1:02:35Speaker 2: again looking to differentiate themselves from the other pharmacy practice
- 1:02:38Speaker 2: settings and how can we work together. So we're developing
- 1:02:41Speaker 2: a program for them, and.
- 1:02:42Speaker 1: We're really excited.
- 1:02:43Speaker 2: We're also going to use that for some of our
- 1:02:45Speaker 2: newer pharmacy graduates who can't yet sit for the CSP
- 1:02:49Speaker 2: and earn the CSP credential because there's you know, a
- 1:02:51Speaker 2: number of practice hours involved with that, so it's kind
- 1:02:54Speaker 2: of kind of be a bridge like, Hey, I'm working
- 1:02:55Speaker 2: in specialty pharmacy and I know it, and I have
- 1:02:57Speaker 2: the certificate and you know, I'll earn the CSP when
- 1:02:59Speaker 2: I can, but just.
- 1:03:00Speaker 1: Trying to again differentiate them.
- 1:03:02Speaker 2: So we're really excited, and you know, hope to work
- 1:03:05Speaker 2: with Quebec's kind of its own little entity that province.
- 1:03:08Speaker 2: And then you know, we have friends too at the
- 1:03:09Speaker 2: Neighborhood Association of Canada that we work with, so hoping
- 1:03:13Speaker 2: to extend that over with them as well.
- 1:03:15Speaker 6: That's awesome.
- 1:03:15Speaker 5: Yeah, Well, I'm excited about an ASP twenty twenty five.
- 1:03:18Speaker 5: We're definitely going to be there continuing to support you.
- 1:03:22Speaker 5: What do you want to tell people that are listening
- 1:03:24Speaker 5: to Access to Pharmacy twenty twenty five post show. Is
- 1:03:29Speaker 5: there anything you kind of want to like note before
- 1:03:31Speaker 5: we wrap up?
- 1:03:34Speaker 2: Hmmm, well, I mean obviously we want to we're looking
- 1:03:36Speaker 2: for sponsors, right, we want to, We absolutely want we
- 1:03:39Speaker 2: want to.
- 1:03:40Speaker 1: We want to have sponsors, and we.
- 1:03:41Speaker 2: Would just want people to be aware of, you know,
- 1:03:43Speaker 2: the issues and how it's more important than ever, right
- 1:03:47Speaker 2: with all of the pressures I think on specialty, on reimbursement,
- 1:03:50Speaker 2: you know, the IRA, what's happening with the three forty
- 1:03:53Speaker 2: B programs, some of the you know the legislations that's
- 1:03:57Speaker 2: passing in different states across the country that we have
- 1:03:59Speaker 2: to come together. Right, we want to maintain patient access,
- 1:04:02Speaker 2: we want to maintain patient choice. Right, we need to
- 1:04:05Speaker 2: be concerned about some anti competitive practices from a multitude
- 1:04:09Speaker 2: of stakeholders.
- 1:04:10Speaker 4: Right.
- 1:04:10Speaker 2: I think we talk a lot about PBM reform, but
- 1:04:12Speaker 2: there's some other threats now too. Yeah, Right, we just
- 1:04:15Speaker 2: want to make sure I think that we're creating a fair,
- 1:04:18Speaker 2: imbalanced marketplace where competitions encourage.
- 1:04:21Speaker 1: Right, not stifled.
- 1:04:22Speaker 2: Not everybody to have the opportunity to compete, and we
- 1:04:24Speaker 2: want to kind of challenge each other to get better.
- 1:04:27Speaker 5: Yeah exactly, Yeah, I like that, all right, Sheila Arquette.
- 1:04:30Speaker 5: We appreciate you so much always being a part of
- 1:04:33Speaker 5: the show, being part of our network. I mean, you've
- 1:04:35Speaker 5: you've been the you've been the conduit of specialty pharmacy
- 1:04:39Speaker 5: to the Pharmacy Podcast Network, bringing us content a month
- 1:04:41Speaker 5: after month. That's been amazing. Thank you so much for that,
- 1:04:45Speaker 5: and we can't wait to spend time with you in Colorado.
- 1:04:47Speaker 1: Awesome. Well, thank you so much for your spartan.
- 1:04:49Speaker 2: I mean, you are the pharmacy champion, right for all
- 1:04:51Speaker 2: of us, all different pharmacy practice settings. I think it's
- 1:04:54Speaker 2: a fabulous ecosystem, it's a fabulous profession, right, And you
- 1:04:57Speaker 2: do a lot to raise awareness to the value that
- 1:04:59Speaker 2: pharmacists provide because I think sometimes they're so busy taking
- 1:05:02Speaker 2: care of their patients they're not doing it for themselves.
- 1:05:04Speaker 5: True. Absolutely, yep, all right, Chill Arquet. NASP sign up
- 1:05:09Speaker 5: NASP twenty twenty five. Go to their website na.
- 1:05:14Speaker 1: Sp n E T dot oorg net.
- 1:05:17Speaker 5: RG, NASP net dot RG and you heard it here
- 1:05:22Speaker 5: on the Pharmacy podcast network Access twenty five Access to
- 1:05:32Speaker 5: Pharmacy here Assembia in Las Vegas, first time exhibitors prosper Ai.
- 1:05:41Speaker 5: I'm excited to have you here, Xavier. Tell me about
- 1:05:43Speaker 5: your organization and how you assist the especially pharmacy ecosystem.
- 1:05:49Speaker 12: Yeah, so we create AI boys agents, so agents that
- 1:05:54Speaker 12: speak on the phone with patients and payers, and we
- 1:05:59Speaker 12: implement these in the specialty pharmacy system. So for patient conversations,
- 1:06:05Speaker 12: prescription refills, inbound calls about the prescriptions, or incoming conversations,
- 1:06:12Speaker 12: we're able to do them with AI and reduce the
- 1:06:15Speaker 12: burden on the pharmacy tepicians. And also when you do
- 1:06:19Speaker 12: benefit breifications automatically with electronic exchange, but then we do
- 1:06:23Speaker 12: outbound calls to payers on the phone.
- 1:06:26Speaker 5: So this makes a lot of sense to me. So
- 1:06:28Speaker 5: the banking industry, the automobile industry, the hospital system industry,
- 1:06:34Speaker 5: they've always they've all leveraged artificial intelligence voice communication with
- 1:06:41Speaker 5: people so that you can kind of like navigate calls
- 1:06:44Speaker 5: and things. So how is specially pharmacy different from those
- 1:06:47Speaker 5: other organizations? How is prosper Ai focused specifically on specially pharmacy.
- 1:06:54Speaker 12: Yeah, So what we've done is we use the generativity technology,
- 1:06:57Speaker 12: like the CHGBT style technology, and so is very conversational.
- 1:07:01Speaker 12: It's not like a press one, press two, press three,
- 1:07:03Speaker 12: but actually you can have of the cough conversations with it.
- 1:07:07Speaker 12: And we've tailored it to like specialty pharmacy, see by
- 1:07:10Speaker 12: doing use cases that are relevant for them. So the
- 1:07:14Speaker 12: prescription refills, we've got like do thousands of these kind
- 1:07:17Speaker 12: of calls. We know where the edge cases that happen,
- 1:07:20Speaker 12: and like make sure we've got like great conversations with
- 1:07:22Speaker 12: patients to get them the information they need.
- 1:07:25Speaker 5: All right, So I was in the farm. The way
- 1:07:27Speaker 5: I entered pharmacy was through pharmacy technology. So I worked
- 1:07:31Speaker 5: in the institutional pharmacy space, long term care pharmacy, institutional
- 1:07:36Speaker 5: in combo shops like community pharmacy. So the pharmacy management system,
- 1:07:42Speaker 5: the pioneers and the prim arxes and the Suite rxes
- 1:07:46Speaker 5: and the RX thirties and all of that. Our organization
- 1:07:49Speaker 5: out there talk to me about integration with your voice
- 1:07:53Speaker 5: systems and then those PMS systems.
- 1:07:56Speaker 12: Yes, so we've got two types of integrations. We do
- 1:08:00Speaker 12: API integration so directly into the systems, and so when
- 1:08:05Speaker 12: the AI voice is speaking to the patients, it knows
- 1:08:07Speaker 12: information about the prescription, like when it's delivered, which time
- 1:08:11Speaker 12: of prescription it was. And another way of integrating is
- 1:08:15Speaker 12: like we do like what's like IRPA integration, So we
- 1:08:19Speaker 12: get like a logging into the system as if we
- 1:08:22Speaker 12: were a user, and then we're able to get the
- 1:08:25Speaker 12: information from the system directly is clicking the robot that
- 1:08:31Speaker 12: clicks the system. So more lightweight kind of integration.
- 1:08:35Speaker 5: Do you think that describe to the listeners how the
- 1:08:39Speaker 5: AI shifts. So if there's an NDC number that's about
- 1:08:43Speaker 5: a blood disorder and the patient has to kind of
- 1:08:47Speaker 5: follow a specific treatment set, is the AI starting to
- 1:08:51Speaker 5: get proactive where it's saying day thirty, Hey, listen, is
- 1:08:56Speaker 5: it time to refill your ABC medication or whatever it is.
- 1:09:00Speaker 5: Talk to us a little bit more about how it
- 1:09:02Speaker 5: starts to interact with the patients.
- 1:09:04Speaker 12: Yes, so there's event triggers. So in the same way
- 1:09:07Speaker 12: as like you would with your pharmacy technician and you
- 1:09:09Speaker 12: would say, hey, after thirty days, reach out to patients,
- 1:09:13Speaker 12: and like here is like a work list of patients
- 1:09:15Speaker 12: to reach out. We configure that in the system and
- 1:09:19Speaker 12: we say okay, now, instead of like a human to
- 1:09:21Speaker 12: have like that task list, it's now the AI.
- 1:09:24Speaker 5: That does it.
- 1:09:24Speaker 12: And so we create specific AIS for specific use cases,
- 1:09:28Speaker 12: whether it's for example, if you have a prescription and
- 1:09:31Speaker 12: no one has picked it up in ten days, we
- 1:09:33Speaker 12: create an AI that like on day ten, does an
- 1:09:36Speaker 12: outbound call to the specific patient and reminds them of
- 1:09:39Speaker 12: the prescription. And so there's these events that are triggered
- 1:09:44Speaker 12: by the system to the call.
- 1:09:46Speaker 5: All right, So if someone's listening to us right now,
- 1:09:49Speaker 5: especially pharmacy, they're like, we want this talk to us
- 1:09:53Speaker 5: about how our listeners can get a hold of you.
- 1:09:55Speaker 12: Yeah, so they can go to get prosper dot ai
- 1:10:00Speaker 12: or find us on LinkedIn and my email address also
- 1:10:04Speaker 12: like Xavier dot tegracia at, get prosper dot.
- 1:10:07Speaker 5: Ai, Get prosper dot ai. Yes, correct, prosper dot ai.
- 1:10:12Speaker 5: You heard it. You heard it here on the Pharmacy
- 1:10:15Speaker 5: Podcast Network. I'd like to have you back on this
- 1:10:18Speaker 5: weekend Pharmacy and let's talk more about how artificial intelligence
- 1:10:22Speaker 5: is starting to interact with our patients and it's going
- 1:10:25Speaker 5: to start to become more much more and more accepted
- 1:10:28Speaker 5: today than it was say five years ago, when everybody's like,
- 1:10:30Speaker 5: I don't want to deal with AI now all of
- 1:10:32Speaker 5: a sudden, if it's more contextual, if it's more personalized,
- 1:10:36Speaker 5: people are going to accept it. So I want to
- 1:10:37Speaker 5: have you back at Xavier.
- 1:10:39Speaker 6: Yeah, we love it.
- 1:10:39Speaker 12: And what we've seen to that point is that as
- 1:10:42Speaker 12: long as you can get the job done for the patient,
- 1:10:45Speaker 12: patients are totally fine speaking with AIA. Actually they've been
- 1:10:48Speaker 12: picking to Alexa and like other AI t proractively go
- 1:10:51Speaker 12: to CHAGPT. Right, So if you can get the job done,
- 1:10:54Speaker 12: it's great. It doesn't work then like no tolerance and
- 1:10:57Speaker 12: like we've had twenty years of bad experiences we've iv
- 1:11:00Speaker 12: is right truth, That's what's exciting about the moment now,
- 1:11:03Speaker 12: Like with all the genitive AI technology, really like the
- 1:11:05Speaker 12: experience is significantly better.
- 1:11:07Speaker 5: I like it all right, Xavier, thank you so much
- 1:11:09Speaker 5: for being part of the A x S twenty five
- 1:11:13Speaker 5: Access to Pharmacy post show.
- 1:11:15Speaker 12: Awesome. Thank you very much,